What factors led to the 30% decrease in enterprise adoption of SenseTime's SenseME body analysis software in Q2 compared to Q1?

Introduction

The 30% decrease in enterprise adoption of SenseTime's SenseME body analysis software in Q2 compared to Q1 is a significant issue that requires thorough investigation. I'll approach this problem systematically, focusing on identifying potential root causes, validating hypotheses, and developing both short-term and long-term solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be seasonal factors at play. Is Q2 typically a slower quarter for enterprise software adoption in this industry?

Why it matters: Seasonal trends could explain the decrease and inform our solution approach. Expected answer: Q2 is usually consistent with Q1 in terms of adoption rates. Impact on approach: If seasonal, we'd focus on strategies to boost Q2 performance; if not, we'd investigate other factors.

• Considering the enterprise focus, I'm curious about the sales cycle. Has there been any change in the average sales cycle length from Q1 to Q2?

Why it matters: Longer sales cycles could delay adoptions and impact quarterly numbers. Expected answer: Sales cycle length has remained relatively constant. Impact on approach: If longer, we'd examine sales process changes; if not, we'd look at other adoption barriers.

• Given the body analysis focus, I'm wondering about privacy concerns. Have there been any recent regulatory changes or high-profile incidents related to biometric data privacy?

Why it matters: Privacy issues could significantly impact enterprise willingness to adopt. Expected answer: No major regulatory changes, but some media coverage of privacy concerns in the industry. Impact on approach: If privacy is a factor, we'd prioritize addressing these concerns in our solution.

• Thinking about the product itself, have there been any significant updates or changes to SenseME between Q1 and Q2?

Why it matters: Product changes could affect adoption rates positively or negatively. Expected answer: A minor update was released at the end of Q1. Impact on approach: If changes occurred, we'd investigate their impact on user experience and adoption.